PATENT CLAIM ANALYSIS

Application Number: 16060880
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "139100"]

Abstract:
The present invention provides detection reagents and method for determining risk of traumatic brain injury (TBI) and/or susceptibility to neurodegenerative disease in a subject.

Claim (Index 10):
A nucleic acid encoding an antibody that preferentially recognizes TBI-associated tau, wherein the nucleic acid sequence has at least 95% sequence identity of any one of SEQ ID NO: 41, 43, 45, 47, 49, 51, 53 or 55.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 94.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15479110', '14434742', '15424444', '15114356', '14324289']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7283367230703107
- 35 USC 102 Novelty (BERT): 0.5488180672563742
- Combined Prediction Score: 0.7103848574889171
- Mean Citation Score: 373.356624
- Max Citation Score: 399.37433
- Similarity Product: 265.52614053564844

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test